A new method for constructing tumor specific gene co-expression networks based on samples with tumor purity heterogeneity
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Motivation: Tumor tissue samples often contain an unknown fraction of stromal cells. This problem is widely known as tumor purity heterogeneity (TPH) was recently recognized as a severe issue in omics studies. Specifically, if TPH is ignored when inferring co-expression networks, edges are likely to be estimated among genes with mean shift between non-tumor- and tumor cells rather than among gene pairs interacting with each other in tumor cells. To address this issue, we propose Tumor Specific Net (TSNet), a new method which constructs tumor-cell specific gene/protein co-expression networks based on gene/protein expression profiles of tumor tissues. TSNet treats the observed expression profile as a mixture of expressions from different cell types and explicitly models tumor purity percentage in each tumor sample. Results: Using extensive synthetic data experiments, we demonstrate that TSNet outperforms a standard graphical model which does not account for TPH. We then apply TSNet to estimate tumor specific gene co-expression networks based on TCGA ovarian cancer RNAseq data. We identify novel co-expression modules and hub structure specific to tumor cells. Availability and implementation: R codes can be found at https://github.com/petraf01/TSNet. Supplementary information: Supplementary data are available at Bioinformatics online.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
High-dimensional graphs and variable selection with the Lasso
Meinshausen, N., & Bühlmann, P. (2006) · The Annals of Statistics · doi:10.1214/009053606000000281 · Cited by 2,521 · cited 1×
“There are many recent works on applying high-dimensional GGMs under sparsity and/or structural assumptions to infer gene coexpression networks (Friedman et al., 2008; Meinshausen and Bühlmann, 2006; Schäfer and Strimmer, 2005; Yuan and Lin, 2007), including our previous works (Cheng et al.”
Similarity network fusion for aggregating data types on a genomic scale
Wang, B., Mezlini, A. M., Demir, F., Fiume, M., Tu, Z., Brudno, M., Haibe-Kains, B., & Goldenberg, A. (2014) · Nature Methods · doi:10.1038/nmeth.2810 · Cited by 2,036
Model selection and estimation in the Gaussian graphical model
Yuan, M., & Lin, Y. (2007) · Biometrika · doi:10.1093/biomet/asm018 · Cited by 1,627 · cited 1×
“There are many recent works on applying high-dimensional GGMs under sparsity and/or structural assumptions to infer gene coexpression networks (Friedman et al., 2008; Meinshausen and Bühlmann, 2006; Schäfer and Strimmer, 2005; Yuan and Lin, 2007), including our previous works (Cheng et al.”
Peng, J., Zhu, J., Bergamaschi, A., Han, W., Noh, D.-Y., Pollack, J. R., & Wang, P. (2010) · The Annals of Applied Statistics · doi:10.1214/09-aoas271 · Cited by 211
Self-citationNURD: an implementation of a new method to estimate isoform expression from non-uniform RNA-seq data
Ma, X., & Zhang, X. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-220 · Cited by 14 · cited 1×
“…fraction of tumor cells in clinical tumor samples by using next-generation sequencing data (Gong and Szustakowski, 2013; Larson and Fridley, 2013; Ma and Zhang, 2013; Su et al., 2012), gene expression microarray data (Ahn et al. 2013; Bolen et al. 2011; Erkkilä et al. 2010; Shen-Orr et al.,…”
Method
Cited by
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
Self-citationIntegrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., da Veiga Leprevost, F., Reva, B., Lih, T.-S. M., Chang, H.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.007 · Cited by 730
“TSNet (Petralia et al., 2018) was used to account for this tumor heterogeneity and identify proteins that are differentially expressed between pure-tumor and pure-NAT cells.”
MethodSelf-citationA proteogenomic portrait of lung squamous cell carcinoma
Satpathy, S., Krug, K., Jean Beltran, P. M., Savage, S. R., Petralia, F., Kumar-Sinha, C., Dou, Y., Reva, B., Kane, M. H., Avanessian, S. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.016 · Cited by 377
Self-citationIntegrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Petralia, F., Tignor, N., Reva, B., Koptyra, M., Chowdhury, S., Rykunov, D., Krek, A., Ma, W., Zhu, Y., Ji, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.044 · Cited by 317
“A. Distribution of immune and stromal scores from ESTIMATE (Yoshihara et al., 2013), as well as tumor purity estimates from TSNet (Petralia et al., 2018) across different proteomic clusters.”
InfluentialSelf-citationSynthetic data generation methods in healthcare: A review on open-source tools and methods
Pezoulas, V. C., Zaridis, D. I., Mylona, E., Androutsos, C., Apostolidis, K., Tachos, N. S., & Fotiadis, D. I. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.07.005 · Cited by 263
Cancer proteogenomics: current impact and future prospects
Mani, D. R., Krug, K., Zhang, B., Satpathy, S., Clauser, K. R., Ding, L., Ellis, M., Gillette, M. A., & Carr, S. A. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00446-5 · Cited by 229
Metadata
- Authors
- Petralia, F., Wang, L., Peng, J., Yan, A., Zhu, J., & Wang, P.
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-06-27
- Volume
- 34
- Issue
- 13
- Pages
- i528-i536
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- OpenAlex
- W2807881515
- Cited by
- 30
- References
- 6
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.